VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19
| Errataetall: |
CommentOn: N Engl J Med. 2023 Feb 2;388(5):406-417. - PMID 36577095 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:388 |
|---|---|
| Enthalten in: |
The New England journal of medicine - 388(2023), 25 vom: 22. Juni, Seite 2395 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Lin, Dan-Yu [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
7R9A5P7H32 |
|---|
| Anmerkungen: |
Date Completed 23.06.2023 Date Revised 01.09.2023 published: Print CommentOn: N Engl J Med. 2023 Feb 2;388(5):406-417. - PMID 36577095 Citation Status MEDLINE |
|---|
| doi: |
10.1056/NEJMc2305030 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM358444004 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM358444004 | ||
| 003 | DE-627 | ||
| 005 | 20231226074743.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1056/NEJMc2305030 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1194.xml |
| 035 | |a (DE-627)NLM358444004 | ||
| 035 | |a (NLM)37342930 | ||
| 035 | |a (PII)10.1056/NEJMc2305030#sa1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Lin, Dan-Yu |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19 |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 23.06.2023 | ||
| 500 | |a Date Revised 01.09.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentOn: N Engl J Med. 2023 Feb 2;388(5):406-417. - PMID 36577095 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a nirmatrelvir |2 NLM | |
| 650 | 7 | |a 7R9A5P7H32 |2 NLM | |
| 650 | 7 | |a Ritonavir |2 NLM | |
| 650 | 7 | |a O3J8G9O825 |2 NLM | |
| 650 | 7 | |a GS-621763 |2 NLM | |
| 650 | 7 | |a 83BU3492RP |2 NLM | |
| 700 | 1 | |a Fleming, Thomas R |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The New England journal of medicine |d 1945 |g 388(2023), 25 vom: 22. Juni, Seite 2395 |w (DE-627)NLM000008184 |x 1533-4406 |7 nnns |
| 773 | 1 | 8 | |g volume:388 |g year:2023 |g number:25 |g day:22 |g month:06 |g pages:2395 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1056/NEJMc2305030 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 388 |j 2023 |e 25 |b 22 |c 06 |h 2395 | ||